-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-fullreport.pdf
April 01, 2018 - clock‐watching, requesting specific medications and doses), which are misunderstood
7
by clinicians as drug-seeking
-
www.cahps.ahrq.gov/patient-safety/reports/liability/etchegaray.html
August 01, 2017 - Care Medication Safety: Stakeholders' Perspectives
Medication Discrepancies and Potential Adverse Drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - treatments given for major
depression.
5
Data from the 2010–2011 National Survey on Drug … Behavioral health trends in the United States: Results from
the 2014 National Survey on Drug Use and
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - treatments provided for major depression.
5
Data from the 2010–2011 National Survey on Drug … Behavioral health
trends in the United States: Results from the 2014 National Survey on Drug Use and
-
www.cahps.ahrq.gov/sites/default/files/publications/files/finalsummary.pdf
February 21, 2016 - identify service gaps, opportunities for better care
coordination, and incidences of psychotropic drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - • At least four asthma medication dispensing events (Appendix 1 - Asthma Drug and Device
List, see … account for almost 5 million physician visits (Akinbami, 2006), and their
average annual prescription drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-figure-1-tables-1-5.pdf
January 01, 2011 - it should contain the following elements:
a. current problem list
b. current medication list
c. drug … following elements:
a. problem list at time of discharge
b. medication list at time of discharge
c. drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/case_example_1.pdf
October 01, 2016 - reported they would add a consulting psychiatrist “on
quick dial” for help with diagnosis more than drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/teamstepps/instructor/fundamentals/module6/igmutualsupp.pdf
February 19, 2014 - Clara, an
experienced pharmacy technician, questions the drug dosage. Dr.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallpxreports-ig.pdf
November 09, 2017 - AHRQ's Safety Program for Nursing Homes: On-Time Falls Prevention Training
AHRQ’s Safety Program for Nursing Homes: On-Time Falls Prevention Training 1
On-Time Falls
Prevention:
Reports
AHRQ’s Safety Program for Nursing
Homes: On-Time Falls Prevention
Training
Slide 1: Introduction to Falls Pr…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/case_example_4.pdf
October 01, 2016 - worker working as a
behavioral health clinician.
4 MA
1 Occupational Health Manager Licensed for drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0206-technicalspecs.pdf
May 01, 2016 - related to psych factors 307.81
Cluster headaches/other trigeminal autonomic cephaligias 339.0x
Drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0084coding.xls
January 01, 2012 - FFS
PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug … 2.16.840.1.113883.3.526.2.1505 Hormonal Contraceptives Medication RxNorm 2012 389221 Etonogestrel 68 MG Drug … 2.16.840.1.113883.3.526.2.1505 Hormonal Contraceptives Medication RxNorm 2012 804156 Levonorgestrel 0.000833 MG/HR Drug
-
www.cahps.ahrq.gov/patient-safety/reports/liability/crane.html
August 01, 2017 - Care Medication Safety: Stakeholders' Perspectives
Medication Discrepancies and Potential Adverse Drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
November 01, 2019 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Seizure: Report
1
Ratio of Magnetic Resonance Imaging Scans to
Computed Tomography Scans for the Evaluation of
Children with Atraumatic Seizure
Section 1. Basic Measure Information
1.A. Mea…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-fullreport.pdf
November 01, 2019 - Overuse of Computed Tomography Scans for the Evaluation of Children with a First Generalized Afebrile, Atraumatic Seizure: Report
Overuse of Computed Tomography Scans for the
Evaluation of Children with a First Generalized
Afebrile, Atraumatic Seizure
Section 1. Basic Measure Information
1.A. Measure Name
Ove…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-192-fullreport.pdf
November 01, 2019 - Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure: Final Report
Overuse of Imaging for the Evaluation of Children with
Simple Febrile Seizure
Section 1. Basic Measure Information
1.A. Measure Name
Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure
1.B. M…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-fullreport.pdf
November 01, 2017 - *The addition of or an increase in a continuous infusion of any cardioactive drug within the last
24 … heart disease, unstable shock
(addition of or increase in a continuous infusion of any cardioactive drug
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
June 01, 2018 - Documentation of Heart Rate During Fluid Resuscitation for Children With Severe Sepsis or Septic Shock
1
Documentation of Heart Rate During Fluid
Resuscitation for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Documentation of Heart Rate During Fluid Resu…
-
www.cahps.ahrq.gov/patient-safety/reports/liability/pichert.html
August 01, 2017 - Care Medication Safety: Stakeholders' Perspectives
Medication Discrepancies and Potential Adverse Drug